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Abstract The rationale for intrathoracic impedance
(Z) detection of worsening heart failure (HF) presupposes
that changes in Z reflect changes in pulmonary congestion,
but is confounded by poor specificity in clinical trials. We
therefore tested the hypothesis that Z is primarily affected
by tissue/water content in proximity to electrodes rather
than by lung water distribution between electrodes through
the use of a new computational model for deriving the
near-field impedance contributions from the various elec-
trodes. Six sheep were implanted with a left atrial pressure
(LAP) monitor and a cardiac resynchronization therapy
device which measured Z from six vectors comprising of
five electrodes. The vector-based Z was modelled as the
summation of the near-field impedances of the two elec-
trodes forming the vector. During volume expansion an
acute increase in LAP resulted in simultaneous reductions
in the near-field impedances of the intra-cardiac electrodes,
while the subcutaneous electrode showed several hours of
lag (all p \ 0.001). In contrast, during the simulated for-
mation of device-pocket edema (induced by fluid injection)
the near-field impedance of the subcutaneous electrode had
an instantaneous response, while the intra-cardiac elec-
trodes had a minimal inconsistent response. This study
suggests that the primary contribution to the vector based Z
is from the tissue/water in proximity to the individual
electrodes. This novel finding may help explain the limited
utility of Z for detecting worsening HF.
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1 Introduction
Despite treatment advances and more intensive clinical
monitoring, heart failure (HF) remains one of the most
common causes for hospitalization and is associated with
high morbidity, mortality and economic costs [1]. The
increasing use of implantable cardioverter defibrillators
(ICD) and cardiac resynchronization therapy (CRT) devi-
ces in patients with HF makes it possible to remotely
monitor intrathoracic impedance (Z) in combination with
other physiological parameters [2]. Z measurements using
the right ventricular (RV) shocking coil to the device case
vector (RVcoil-Case) are traditionally thought to represent
the resistance to electrical flow across a field extending
through the lungs, such that changes in Z can be interpreted
to reflect changes in thoracic fluid volume and pulmonary
congestion [3, 4]. Based on this premise several studies
have shown that it is possible to use Z to predict and
potentially reduce hospitalizations for acute decompen-
sated HF (ADHF) [5, 6]. However, because of the limited
specificity and sensitivity of Z monitoring when using the
RVcoil-Case vector [5, 7], more recent studies have
explored the use of alternative and combination vectors
from CRT leads [8–10].
Pre-clinical studies using multiple vectors have shown
that each vector changes at a different rate and magnitude
C. J. Charles (&)  M. T. Rademaker  I. C. Melton 
R. W. Troughton
Christchurch Heart Institute, University of Otago,
P.O. Box 4345, Christchurch, New Zealand
e-mail: chris.charles@otago.ac.nz
D. Gutfinger  N. L. Eigler  F. Qu
Implantable Electronic Systems Division, St. Jude Medical,
Sylmar, CA, USA
N. L. Eigler
Division of Cardiology, Cedars-Sinai Medical Center, UCLA
School of Medicine, Los Angeles, CA, USA
123
J Clin Monit Comput (2015) 29:65–76
DOI 10.1007/s10877-014-9570-x
in response to the development of pacing-induced HF [9,
10]. The left ventricular (LV) ring electrode to device case
vector (LVring-Case) demonstrated the fastest rate and
greatest magnitude of change, and correlated well with left
atrial pressure (LAP). A recent clinical study reported that
a combination of Z vectors, rather than Z from a single
vector can successfully identify increases in thoracic fluid
volume that will culminate in ADHF. Using a combination
vector from either CRT or ICD leads showed improved
sensitivity and a lower false positive rate compared with
the single RVcoil-Case vector [11].
In order to more effectively exploit the availability of Z
from multiple vectors, we sought to gain better insight into
what is being measured by these vectors. The electric
current flowing between two electrodes forming a vector
does not necessarily travel along a straight line across the
lungs, but more likely along pathways of lesser resistance.
We, therefore, hypothesized that the most significant con-
tribution to the measured Z is from the electrode-tissue
interface where there is high impedance to electrical flow,
and that beyond this interface the contribution to the
measured Z is negligible [12]. This is because beyond the
electrode-tissue interface the current finds its way to flow
through low resistance structures, such as blood vessels,
that do not have a significant contribution to the measured
Z. If Z primarily depends on the electrode-tissue interface,
then it provides a measure of the local tissue characteristics
surrounding the two electrodes rather than the character-
istics of tissues located farther away between the elec-
trodes. This new interpretation may help explain why
recent clinical trials have shown that monitoring of Z has
limited effectiveness in detecting ADHF [13, 14], partic-
ularly in the early months post-device implant when there
are significant non-HF related changes occurring at the
electrode-tissue interface. To test the hypothesis that Z
primarily reflects local tissue characteristics we evaluated a
new computational model for deriving the near-field
impedance contributions from the various electrodes and
conducted a pre-clinical experiment to illustrate how near-
field impedances may be monitored at multiple sites.
2 Methods
The study protocol was approved by the Animal Ethics
Committee of the University of Otago, Christchurch, New
Zealand.
2.1 Implantation Procedure and Devices
Under general anesthesia (induced by 15 mg/kg thiopen-
tone; maintained by halothane/nitrous oxide inhalation) six
sheep were implanted via the right jugular vein with an
LAP monitor (HeartPODTM ISL) and three standard
transvenous bipolar pacing/defibrillation leads with the tip
electrodes fixed in the right atrial (RA) appendage, RV
apex and LV epicardial region via the coronary sinus. The
leads were attached to a CRT device (PromoteTM RF) that
was implanted subcutaneously over the left chest wall. The
CRT device provided Z measurements along six vectors:
V1 = LVring-Case; V2 = RVring-Case; V3 = RAring-
Case; V4 = RVcoil-Case; V5 = LVring-RVring; and
V6 = LVring-RAring [9, 10]. The LAP monitor was
implanted into the left atrium via a trans-septal catheteri-
zation, and provided direct LAP waveform measurements
via telemetry communication [15, 16]. All implanted
devices were manufactured by St Jude Medical, Implant-
able Electronic Systems Division in Sylmar, CA, USA.
Post-operatively, animals recovered for a minimum of
5 weeks to allow the Z measurements to stabilize.
2.2 Acute study protocols
Following the stabilization period, sheep were studied on
separate days as follows:
2.2.1 Intravascular volume expansion in normal sheep
(pre-pacing)
Sheep received a 4-h intravenous (IV) infusion of Dex-
tran (initial dose 15 ml/kg over 30 min, then titrated to
maintain LAP at approximately 15 mmHg above baseline
values).
2.2.2 Induction of Congestive HF
Sheep underwent 7 days of rapid RV pacing at 190 bpm to
induce a state of moderate stable congestive HF. This rate
of RV pacing consistently raised LAP levels in this animal
model by approximately 10 mmHg [17].
2.2.3 Intravascular volume expansion during congestive
HF
Sheep received a 4-h IV infusion of Dextran (as above) in
the HF state. Dextran was titrated to raise LAP by
approximately 15 mmHg (from HF baseline levels of
16–17 mmHg to approximately 31–32 mmHg).
2.2.4 Device pocket edema
To simulate the formation of edema within the device
pocket 250 mL of 0.9 % saline was rapidly injected via an
angiocath catheter into the subcutaneous pocket containing
the CRT device case. An additional 250 mL saline bolus
was injected in 5/6 sheep 2 h later.
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2.3 Data Acquisition and Processing
LAP measurements were recorded every 5 min through-
out the acute study protocols as previously described [15,
16]. Z measurements were automatically collected
through the CRT device along all six vectors (V1
through V6) at 7.5 min intervals throughout the acute
study protocols. Using equivalent circuit equations [18],
the measured Z along each vector was modelled as the
sum of the near-field contributions from the two mea-
suring electrodes to produce a set of six linear equations
(Fig. 1). The set of equations was solved algebraically to
determine the near-field impedance contribution (denoted
by ZE or the electrode name) associated with each of the
five electrodes. As outlined in Fig. 1, the ZE associated
with the LVring electrode was computed using the
equations corresponding to two different impedance tri-
angles to yield LV1 and LV2 which were then averaged.
The difference between LV1 and LV2 determined the
measurement error associated with the computational
model.
2.4 Statistics
All results are expressed as mean ± SEM unless otherwise
specified. For each acute study the effect on LAP, Z and ZE
parameters were assessed using one-way repeated mea-
sures analysis of variance (ANOVA). A value of p \ 0.05
was considered statistically significant.
3 Results
3.1 Near-field impedance measurement validation
Near-field impedances (ZE) and the relative contributions
from each of the five electrodes toward the vector-based Z
measurements are summarized in Table 1. As expected, the
highest ZE was associated with the smaller sized electrodes
(LVring, RVring and RAring), while the lowest ZE was
associated with the larger sized electrodes (Case and
RVcoil). Electrode size also influenced the relative contri-
butions from each of the electrodes towards the measured
Z. For a vector between any ring electrode (LVring, RVring,
and RAring) and the Case electrode (V1 through V3), most
of the contribution to Z was found to be from the ring
electrode (77-87 %), while only 13–23 % of the contribu-
tion was from the Case. In contrast, for the RVcoil to Case
vector (V4) most of the contribution to Z was found to be
from the subcutaneous Case electrode (69 %), with only
31 % from the intra-cardiac RVcoil electrode. For the intra-
cardiac vectors that are between two ring electrodes (V5
and V6) the contributions from the two electrodes was
found to be similar. Thus, it appears that for a vector with
different electrode sizes, the smaller electrode or the
electrode that is surrounded by more scar tissue will be the
one that is most influencing any changes in the vector-
based Z measurement.
The error in computing the near-field impedance for the
LVring electrode (Fig. 1) was found to be extremely small
at 2.9 ± 3.8 X (*1 %). This small error in combination
with the observations regarding electrode size influencing
ZE both validate the computational model used for deriving
the near-field impedance contributions to the vector-based
Z measurements.
3.2 Intravascular volume expansion in normal sheep
(pre-pacing)
The total volume of Dextran administered over the 4 h
infusion period ranged between 3,500 and 4,500 mL. LAP
increased from 7 ± 1 to 21 ± 1.4 mmHg by 30 min and
remained stable while Dextran was being infused (Fig. 2).
Once the infusion terminated, LAP gradually fell over
60 min, but remained 2–3 mmHg above baseline levels for
the remainder of the recording period. In comparison, after
a brief delay (30 min), LVring-Case Z fell (p \ 0.001),
reaching a nadir at 285 min and remaining low. ZE from
LVring (p \ 0.001) showed a similar response, achieving a
nadir after 270 min. RVring-Case Z fell without delay
reaching a nadir at 265 min (p \ 0.001). In contrast,
RVcoil-Case Z demonstrated a delayed fall (90 min), and
did not reach nadir till 375 min (p \ 0.001). The RVring,
RVcoil and RAring ZE all fell immediately and abruptly (all
Fig. 1 Methodology for calculating near-field impedance by solving
the algebraic equations of the vector-based (V1–V6) impedance
measurements
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p \ 0.001) mirroring the acute change in LAP, and
reaching nadirs at 45, 30 and 30 min, respectively. Despite
the observation that LAP fell within 60 min following
Dextran infusion, the intra-cardiac ZE measurements
remained suppressed for the duration of the recording
period. Case ZE changes were less consistent, with the level
actually rising initially and ultimately reducing with sig-
nificant lag.
3.3 Induction of congestive HF
Pacing at 190 bpm induced a moderate state of HF as
indicated by rapid and significant increases in LAP, rising
from a pre-pacing baseline of 7 ± 1–16 ± 1 mmHg within
a few hours of pacing, before plateauing (p \ 0.001).
Pacing induced the expected decreases in vector-based Z,
falling from pre-pacing levels of 310 ± 21–257 ± 21 X,
186 ± 12–162 ± 10 X and 61 ± 1–54 ± 2 X for LVring-
Case, RVring-Case and RVcoil-Case, respectively (all
p \ 0.001). Similarly, pacing produced falls in the ZE for
LVring (269 ± 19–220 ± 19 X, p \ 0.001), RVring
(145 ± 12–125 ± 19 X, p = 0.004) and Case (41 ± 2.1
vs. 37 ± 1.9 X, p = 0.014) electrodes. The ZE of the
RVcoil (20.2 ± 2.1–17.5 ± 2.1 X, p = 0.07) and RAring
(215 ± 11–203 ± 11 X, p = 0.16) electrodes also tended
to decline.
3.4 Intravascular volume expansion during congestive
HF
The total volume of Dextran administered over the infusion
period was 2,900–4,000 mL. Acute volume loading
increased LAP from 16 ± 1 to 31 ± 1.2 mmHg by
30 min, with pressures remaining stable for the duration of
the infusion (Fig. 3). LAP gradually reduced following
termination of Dextran infusion, but remained above pre-
Dextran infusion levels. Both LVring-Case and RVcoil-Case
vectors showed a small but consistent rise (both p \ 0.001)
in response to Dextran (Fig. 3), with similar rises observed
for ZE of the LVring (p \ 0.001) and Case (p \ 0.001). In
contrast, RVring-Case vector-based Z and ZE from RVring,
RAring and RVcoil all showed prompt and consistent falls
(all p \ 0.001), reaching nadirs by 37.5 min and remaining
depressed for the duration of the recording period.
3.5 Device pocket edema
There was a small but consistent elevation in LAP
(*2 mmHg; p \ 0.001) during the study day which
appeared unrelated to fluid injection (Fig. 4). All three
vector-based Z showed an immediate decline (all
p \ 0.001) in response to fluid injection into the device
pocket, and remained lower than baseline. ZE from the
Case showed a prompt and dramatic fall in response to
pocket fluid injection (p \ 0.001), dropping from *43 to
*30 X following the first injection, and then to *27 X
following the second injection. In contrast, ZE associated
with the other four electrodes showed minimal and
inconsistent changes unrelated to fluid injection.
4 Discussion
In this study we demonstrate for the first time that changes
in vector-based Z measurements may readily develop in
response to changes occurring at the electrode-tissue
interface, thereby providing a possible mechanism that
explains why Z monitoring has limited sensitivity and
specificity in detecting ADHF [13]. The hypothesis that Z
primarily reflects local tissue characteristics suggests that
non-HF events, such as healing post-implant, lead migra-
tion/dislodgement, and device-pocket infection, can easily
confound the interpretation of changes in Z measurements
[4, 14]. Thus, in the current study we evaluated changes in
both vector-based Z and ZE responses during rapid changes
in LAP induced by volume and non-volume-dependent
mechanisms. Volume loading with dextran is a standard
physiological model designed to acutely increase
Table 1 Mean impedance
measurements with relative
contribution of near-field ZE to
vector-based Z. Data averaged
across all sheep (N = 6) for all
measurements over entire
duration of implants [100 ± 22
(SD) days]






Electrode Mean ± SD
ZE (X)
V1: LVring-Case 306 ± 53 87 % LVring 13 % Case LVring 266 ± 50
V2: RVring-Case 177 ± 29 77 % RVring 23 % Case RVring 137 ± 26
V3: RAring-Case 254 ± 28 84 % RAring 16 % Case RAring 214 ± 26
V4: RVcoil-Case 58 ± 6 31 % RVcoil 69 % Case Case 40 ± 5
V5: LVring-RVring 403 ± 50 66 % LVring 34 % RVring RVcoil 18 ± 5
V6: LVring-RAring 480 ± 58 55 % LVring 45 % RAring
LV1 268 ± 50
LV2 265 ± 50
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intravascular and intracardiac volumes [19, 20]. The rate
and duration of dextran infusion in the current study was
sufficient to increase intravascular and intracardiac vol-
umes with an approximate 15 mmHg rise in LAP, but is
unlikely to have caused pulmonary edema. Rapid ventric-
ular pacing is a well established animal model of conges-
tive HF which consistently induces significant sodium and
water retention, changes in intracardiac volumes and
pressures and pulmonary edema [17]. This model has been
previously used in our lab to study vector-based impedance
changes with the onset and offset of congestive HF, thereby
modelling ADHF decompensation and recovery [10].
Results from the current study confirm that pacing induced
HF not only reduces all vector-based impedances, as pre-
viously shown [10], but also consistently reduces ZE
derived from each of the electrodes.
Results from the current study support our hypothesis that
Z primarily reflects local tissue characteristics by demon-
strating that intrathoracic impedance measurements reflect the















































DextranFig. 2 Mean ± SEM LAP,
vector-based and near-field
impedance responses to acute
intravascular volume expansion
in six normal sheep
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electrodes, rather than the characteristics of tissues located
farther away in the region between the measuring electrodes.
The highest near-field impedance (ZE) was associated with the
smaller-sized LVring, RVring and RAring electrodes which had
greater resistance to electrical flow at the electrode-tissue
interface (Table 1). The lowest ZE was associated with the
Case and RVcoil electrodes, consistent with these electrodes
being larger in size with less resistance to electrical flow. The
LVring electrode had the highest ZE, consistent with this
electrode being surrounded by more tissue and less blood.
To construct the mathematical model we hypothesized
that the current flows along a pathway from the first elec-
trode to the second electrode which includes three com-
ponents; (1) the tissues adjacent to the first electrode; (2)
the tissues and/or blood located farther away between the
two electrodes; and (3) the tissues adjacent to the second
electrode. The measured impedance between the first
electrode and the second electrode therefore can be mod-
elled as the summation of the impedance associated with





















































volume expansion with Dextran
in six sheep with stable pacing-
induced HF
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that the contribution to the measured impedance between
the first and the second electrode is greatest from the 1st
and 3rd components of the pathway, and that the contri-
bution from the 2nd component is significantly lower such
that it may be ignored. We believe this hypothesis to be
correct because the electrical current will find its way to
flow through a pathway between the electrodes that has the
lowest impedance to electrical flow, such as along blood
vessels. Thus, the mathematical model for the measured
impedance between two electrodes was simplified to
consist of only the 1st and 3rd components. Since we had
six measurements of vector based impedance from five
electrodes we were able to compute the contribution from
the LVring electrode in more than one way (LV1 and LV2)
which allowed us to verify our hypothesis that the
impedance associated with the 2nd component pathway
can be ignored.
The most striking example of impedance reflecting the
local tissue and fluid conditions surrounding an electrode was























































Fig. 4 Mean ± SEM LAP,
vector-based and near-field
impedance responses to
injection of fluid into the CRT-
D device pocket in six normal
sheep
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based Z (V1, V2, and V4) fell in response to the injection of
fluid into the device pocket, near-field computation demon-
strated that the marked and precipitous fall in the Case ZE
contributed most, if not all, to the decrease in the vector-based
Z. This can be seen in Fig. 5a where the falls in Z for V1, V2,
and V4 are plotted at 30 min following saline injection into the
pocket. The reduction in Z for V1 and V4 is contributed almost
exclusively by the fall in ZE of the Case electrode, with little if
any contribution from the ZE of the LVring or RVcoil elec-
trodes, respectively. The large accumulation of fluid sur-
rounding the Case resulted in little discernable change in LAP
or ZE for any of the other implanted electrodes located far
away from the device pocket. A similar response pattern in the
measured Z is classically seen whenever a pulse generator is
replaced, which results in the formation of local edema within
the device pocket during the first 24 h, followed by the normal
phases of tissue healing occurring over the subsequent weeks
to months. Thus, device pocket edema induces significant
reductions in the measured Z that may be falsely interpreted
[4]. However, with the ability to remove the contribution of
the Case electrode from the measured vector-based Z, it is
possible to monitor impedance without it being subjected to


















































































































































Fig. 5 Relative contributions of
near-field impedances to
changes in vector based
impedance measured in
response to device pocket saline
injection at 30 min (a); and
intravascular volume expansion
at 30 min (b) and 300 min (c)
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The hypothesis that Z primarily reflects local tissue
characteristics is further supported by the intravascular
volume expansion studies performed both in normal (pre-
pacing) and HF sheep which induced a significant increase
in LAP that was promptly tracked by corresponding
reductions in the ZE measurements from the intra-cardiac
(RVring, RAring and RVcoil) electrodes. The acute and the
delayed responses to intravascular volume expansion in the
normal (pre-pacing) sheep are illustrated in Fig. 5b and c,
respectively. At 30 min following commencement of vol-
ume expansion, which corresponds to the time when LAP
first peaked, there is a dramatic fall in Z for V2 and V4,
whereas for V1 there is a slight unexpected increase
(Fig. 5b). Near-field computation demonstrates that the
acute reduction in Z for V2 and V4 is contributed entirely
by a fall in the ZE for the RVring and RVcoil electrodes,
respectively. Because the RVring and RVcoil electrodes are
located within the RV chamber, a rapid increase in
chamber volume causes more fluid to surround the elec-
trodes and less tissue to be in contact with the electrodes,
such that the near-field contribution to the measured vec-
tor-based Z is proportionally reduced.
Following the 30 min time point the Z for V1 has a
steady decrease (Fig. 2), which is occurring over the time
period when the infused fluid is being redistributed to other
compartments. At the 300 min time point (Fig. 5c) near-
field computation demonstrates that virtually all of the
reduction in Z for V1 is contributed by the fall in the ZE for
the LVring electrode. Although the LVring electrode is
implanted within an epicardial blood vessel, its delayed
response suggests that the LVring electrode is not in direct
communication with the RV blood pool. This may be
secondary to possible formation of scar tissue within the
distal coronary venous implant site (confirmed by autopsy
in some animals) causing obstruction to blood flow.
Importantly, ZE from the LVring electrode was found to be
sensitive to congestion within the adjacent epicardial fat, as
demonstrated post volume expansion in canine studies in
our lab (unpublished observations), and to pericardial fluid
volume and the degree of contact between the LVring
electrode and the pericardial sac [21]. Thus, an increase in
the degree of tissue contact between the LVring electrode
and the pericardial sac as a consequence of an expanding
cardiac chamber volume may explain the unexpected initial
increase observed in response to acute volume infusion,
while the later development of epicardial fat edema may
explain the delayed response. A change in the degree of
contact between the LVring electrode and the pericardial sac
may also occur in response to changes in posture or peri-
cardial fluid volume irrespective of pulmonary congestion,
and may result in false interpretations of the measured
impedance as previously reported [21]. However, the
influence of free flowing pericardial fluid volume and
posture may be less critical in patients with a scarred
pericardial space following open heart surgery, or an epi-
sode of pericarditis.
There were variations in the recovery pattern of the
measured ZE following cessation of volume loading that
depended on the electrode implant location. All five elec-
trodes had a much slower recovery rate in ZE ([12 h)
compared to LAP (*3 h). The intra-cardiac right-sided
electrodes demonstrated a faster recovery compared to the
LVring and Case electrodes. The delay in recovery of








































Fig. 6 Example of vector-
based (left panel) and near-field
(right panel) impedance trend
plots from a canine implanted
with pacing/defibrillation leads
using identical methodology to
that described for sheep in this
study. A micro-dislodgement of
the LV lead occurred on day 18
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previous reported findings [10], and is likely a consequence
of the longer time required to restore the local fluid volume
conditions surrounding the various electrodes, particularly
when located outside the intravascular space. Similarly,
termination of rapid ventricular pacing caused a precipitous
acute fall in LAP, followed by a gradual recovery over the
subsequent 12 h. This was in contrast to the significantly
slower recovery seen in ZE (*3 days—data not shown),
which is consistent with previously reported data for ZV
[10]. The lag seen between ZE and LAP is likely a con-
sequence of ZE being more a reflection of the local volume
and corresponding tissue contact rather than pressure.
4.1 Illustrative case studies
1. Micro-dislodgement. Figure 6 provides an example of
the Z measurements acquired from a canine surgically
prepared in a similar manner to the sheep in this study
[9]. This animal developed a micro-dislodgement of
the LV lead during the third week post-implant. The
trend data demonstrates that during the first 24 h post-
implant there is a significant decrease in the measured
Z across all six vectors, which is consistent with the
development of edema in the vicinity of all five elec-
trodes. During the subsequent weeks the Z measure-
ments gradually increased as the local edema resolved.
However, there is a sudden disturbance in the mea-
sured Z on day 18 post-implant seen across the three
vectors having the LVring in common (V1, V5, and
V6). Examination of the ZE shows that only the LVring
electrode recorded a significant increase, with no
change noted in the contribution from the other four
electrodes. The ability to isolate the micro-dislodge-
ment event into a single electrode additionally supports





















































Hospitalization AVN AblationAF OnsetFig. 7 Example of near-field
impedance trend plots shown
from a patient with ischemic
cardiomyopathy. Patient was
hospitalized following an




therapy and AV node ablation
(AVN)
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2. Hospitalization for ADHF. An example of ZE data
acquired from a 66 year-old patient with ischemic
cardiomyopathy is shown as a trend plot over time in
Fig. 7. This patient provided informed consent to
participate in the clinical trial reported by Binkley and
colleagues [11]. Approximately 2 months following
implant, the patient developed an episode of persistent
atrial fibrillation that resulted in hospitalization for
ADHF. During hospitalization, the patient was treated
with intravenous diuretic therapy, and underwent an
AV-node ablation procedure (Fig. 7). In response to
this treatment, the ZE from the RVring and Case
electrodes increased dramatically, while the rise for the
LVring ZE was more gradual and continued post-
hospital discharge. Interestingly, the ZE from the
RVcoil and RAring electrodes had more noise and
measurement artifact, and did not coincide with the
clinical course. This case illustrates that the response
seen in ZE during the development and recovery from
ADHF varies with the electrode location and the local
tissue characteristics.
5 Summary
Taken together, the results of the present study validate the
computational model used to derive the near-field imped-
ances (ZE), and demonstrate that vector-based Z primarily
depends on the impedance from the tissues in the vicinity
of the measuring electrodes, and therefore, reflects local
tissue characteristics. This finding may explain why vector-
based Z can display changes that do not coincide with
pulmonary congestion, particularly in the early months
post-implant when there are significant changes occurring
at the electrode-tissue interface. This is consistent with the
results from a recent clinical trial which demonstrate that
the positive predictive value of a Z monitoring algorithm is
particularly low in the initial 6 months post-implant, but
subsequently improves over time [13]. Instabilities post-
implant are more likely to occur with Z that are associated
with a passive fixation lead, such as an LV pacing lead,
where there is a greater chance for a micro-dislodgement to
occur (Fig. 6). Therefore, it may be preferable to allow
more time for the electrode-tissue interface to stabilize
before relying on Z measurements for clinical decision
making, or to rely on Z vectors that are derived from an
active fixation lead (RVcoil-Case and RVring-Case). Once
the electrode-tissue interface is stabilized, this study dem-
onstrates that the ZE associated with the intra-cardiac
electrodes (RVring, RAring, and RVcoil) respond faster than
the ZE associated with the LVring and Case electrode to an
expanding intra-cardiac chamber volume. The ZE associ-
ated with the LVring and Case electrodes are additionally
influenced by changes occurring within the pericardial
space or device pocket, which may not coincide with
pulmonary congestion. Therefore, relying on the ZE asso-
ciated with the intra-cardiac electrodes for clinical deci-
sion-making may be more advantageous than other
electrodes or Z vectors.
6 Conclusion
We have reported for the first time a validated method for
determining the relative contributions to the measured
vector-based impedance from the various electrodes, and
have demonstrated that vector-based impedance measure-
ments predominantly reflect physical phenomena occurring
in the vicinity of the measuring electrodes rather than
farther away within the pulmonary parenchyma. Thus, the
near-field computational model offers a new paradigm for
examining impedance data from multi-lead devices which
may prove clinically-useful in monitoring changes at spe-
cific anatomical locations in close proximity to the indi-
vidual recording electrodes. The results of this study help
explain why vector-based impedance measurements may
display changes that do not necessarily correlate with the
presence of pulmonary congestion, and support the
hypothesis that intrathoracic impedance actually measures
local tissue characteristics rather than intervening lung
water.
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